Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Gorelick

Showing results (11-20 of 160) with videos related to

Pageof 16
Sort By:
Biological Psychiatry|May 29, 2007
Regarding "Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system"David A Gorelick
Annals of Internal Medicine|November 23, 2006
Health Insurance Portability and Accountability Act Privacy Rule and research consent documentsDavid A Gorelick
Journal of Cannabis Research|July 3, 2021
Editor's note to: A cannabis oracle? Delphi method not a substitute for randomized controlled trials of cannabinoids as therapeuticsDavid A Gorelick
The Psychiatric Clinics of North America|September 2, 2022
Kratom: Substance of Abuse or Therapeutic Plant?David A Gorelick
The New England Journal of Medicine|December 13, 2023
Cannabis-Related Disorders and Toxic EffectsDavid A Gorelick
Annals of Internal Medicine|April 4, 2018
The Effects of Cannabis Among Adults With Chronic PainDavid A Gorelick
The American Journal of Drug and Alcohol Abuse|September 16, 2014
The relative harms of marijuana and alcoholDavid A Gorelick
The New England Journal of Medicine|October 20, 2006
Counseling plus buprenorphine-naloxone for opioid dependenceDavid A Gorelick
The American Journal of Psychiatry|June 2, 2014
The second-oldest state psychiatric hospital in the United StatesDavid A Gorelick
Expert Review of Clinical Pharmacology|January 16, 2014
Pharmacokinetic approaches to treatment of drug addictionDavid A Gorelick
Pageof 16

Showing results (11-20 of 160) with videos related to

Sort By:
Pageof 16
Biological Psychiatry|May 29, 2007
Regarding "Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system"David A Gorelick
Annals of Internal Medicine|November 23, 2006
Health Insurance Portability and Accountability Act Privacy Rule and research consent documentsDavid A Gorelick
Journal of Cannabis Research|July 3, 2021
Editor's note to: A cannabis oracle? Delphi method not a substitute for randomized controlled trials of cannabinoids as therapeuticsDavid A Gorelick
The Psychiatric Clinics of North America|September 2, 2022
Kratom: Substance of Abuse or Therapeutic Plant?David A Gorelick
The New England Journal of Medicine|December 13, 2023
Cannabis-Related Disorders and Toxic EffectsDavid A Gorelick
Annals of Internal Medicine|April 4, 2018
The Effects of Cannabis Among Adults With Chronic PainDavid A Gorelick
The American Journal of Drug and Alcohol Abuse|September 16, 2014
The relative harms of marijuana and alcoholDavid A Gorelick
The New England Journal of Medicine|October 20, 2006
Counseling plus buprenorphine-naloxone for opioid dependenceDavid A Gorelick
The American Journal of Psychiatry|June 2, 2014
The second-oldest state psychiatric hospital in the United StatesDavid A Gorelick
Expert Review of Clinical Pharmacology|January 16, 2014
Pharmacokinetic approaches to treatment of drug addictionDavid A Gorelick
Pageof 16